Activity of fludarabine in patients (PTS) with de novo B-cell prolymphocytic leukemia (PLL) and the prolymphocytoid variant of chronic lymphocytic leukemia (CLL-PRO).

被引：0
|
作者：
Rodríguez, J [1 ]
O'Brien, S [1 ]
Lerner, S [1 ]
Cortés, J [1 ]
Kantarjian, H [1 ]
Keating, M [1 ]
机构：
[1] Univ Texas, Md Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
423
引用
收藏
页码：104A / 104A
页数：1
相关论文
共 50 条
  • [1] IMMUNOLOGICAL AND CLINICAL FINDINGS IN PROLYMPHOCYTOID TRANSFORMATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL-PRO)
    STARK, AN
    SCOTT, CS
    JONES, RA
    ROBERTS, BE
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) : 836 - 836
  • [2] EFFICACY OF FLUDARABINE, A NEW ADENINE NUCLEOSIDE ANALOG, IN PATIENTS WITH PROLYMPHOCYTIC LEUKEMIA AND THE PROLYMPHOCYTOID VARIANT OF CHRONIC LYMPHOCYTIC-LEUKEMIA
    KANTARJIAN, HM
    CHILDS, C
    OBRIEN, S
    HUH, Y
    BERAN, M
    SCHACHNER, J
    KOLLER, C
    KEATING, MJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 90 (02): : 223 - 228
  • [3] B-cell prolymphocytic leukemia (B-PLL) and chronic lymphocytic leukemia (CLL) express distinct genomic profiles.
    Del Giudice, I
    Osuji, N
    Matutes, E
    Brito-Babapulle, V
    Parry-Jones, N
    Catovsky, D
    [J]. BLOOD, 2005, 106 (11) : 172B - 172B
  • [4] Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia
    Saven, A
    Lee, T
    Schlutz, M
    Jacobs, A
    Ellison, D
    Longmire, R
    Piro, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 37 - 43
  • [5] Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
    Montillo, Marco
    Ricci, Francesca
    Miqueleiz, Sara
    Tedeschi, Alessandra
    Morra, Enrica
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 41 - 52
  • [6] De-Novo B-Cell Prolymphocytic Leukemia
    Menakuru, Sasmith R.
    Roepke, Janet
    Siddiqui, Salahuddin
    [J]. JOURNAL OF HEMATOLOGY, 2023, 12 (02) : 82 - 86
  • [7] PROLONGED BONE-MARROW APLASIA OF REFRACTORY PROLYMPHOCYTOID VARIANT OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RELATED TO FLUDARABINE TREATMENT
    ZINZANI, PL
    TABANELLI, M
    BENDANDI, M
    TURA, S
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1994, 53 (01) : 56 - 58
  • [8] Caught in the act: chronic lymphocytic leukemia progression to B-cell prolymphocytic leukemia
    Lanka, S. M.
    Manogna, D.
    Panse, K.
    Saba, Ns
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S123 - S123
  • [9] Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia
    Shustik, C.
    Turner, A. R.
    Desjardins, P.
    Fernandez, L.
    Rubin, S.
    Larratt, L.
    Duncan, A. M. V.
    Rizi, D.
    Sadura, A.
    Shepherd, L.
    Li, D.
    Rassenti, L.
    Kipps, T.
    [J]. LEUKEMIA, 2010, 24 (01) : 237 - 239
  • [10] Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia
    C Shustik
    A R Turner
    P Desjardins
    L Fernandez
    S Rubin
    L Larratt
    A M V Duncan
    D Rizi
    A Sadura
    L Shepherd
    D Li
    L Rassenti
    T Kipps
    [J]. Leukemia, 2010, 24 : 237 - 239
12345